Ghost Tree Capital, LLC
NEW YORK, NY · CIK 1595851 · 13F filing filed 2024-11-14
No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.
- Legal entityGHOST TREE CAPITAL, LLC (US)
- Part of GHOST TREE CAPITAL MANAGEMENT, LP (US)
- Others nearbyNew York, NY
$275.8m
reported value
-4.0% vs Q2 2024
50positions
40.4%in top 10
9 new
16 added
22 reduced
18 sold out
vs Q2 2024
Options: 2 call positions ($21.1m notional), 2 put positions ($34.2m notional) – listed below, not included above.
Holdings, Q3 2024
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| SAREPTA THERAPEUTICS INC SRPT | $15.0m5.43% | Added +65.0k |
| NOVO-NORDISK A S NVO | $13.1m4.75% | New |
| BLUEPRINT MEDICINES CORP BPMC | $12.9m4.70% | Added +100.0k |
| AXSOME THERAPEUTICS INC AXSM | $12.1m4.40% | Reduced -15.0k |
| TARSUS PHARMACEUTICALS INC TARS | $11.5m4.17% | Added +115.0k |
| PERSPECTIVE THERAPEUTICS INC CATX | $10.0m3.63% | Reduced -175.0k |
| CG ONCOLOGY INC CGON | $9.4m3.42% | Reduced -10.0k |
| ROIVANT SCIENCES LTD ROIV | $9.2m3.35% | Reduced -200.0k |
| VAXCYTE INC PCVX | $9.1m3.31% | Reduced -70.0k |
| VIKING THERAPEUTICS INC VKTX | $8.9m3.21% | Added +45.0k |
| SYNDAX PHARMACEUTICALS INC SNDX | $8.7m3.14% | Added +100.0k |
| JANUX THERAPEUTICS INC JANX | $8.6m3.13% | Added +140.0k |
| ASCENDIS PHARMA A/S SPONSORED ADR | $7.8m2.84% | Reduced -34.2k |
| CRINETICS PHARMACEUTICALS IN CRNX | $7.7m2.78% | Reduced -90.0k |
| SOLENO THERAPEUTICS INC SLNO | $7.6m2.75% | Reduced -150.0k |
| TG THERAPEUTICS INC TGTX | $7.3m2.63% | Reduced -190.0k |
| REZOLUTE INC RZLT | $7.2m2.59% | Added +53.5k |
| PHATHOM PHARMACEUTICALS INC PHAT | $6.8m2.46% | Reduced -225.0k |
| MOONLAKE IMMUNOTHERAPEUTICS MLTX | $6.5m2.35% | Reduced -171.6k |
| OLEMA PHARMACEUTICALS INC OLMA | $6.4m2.32% | Reduced -15.0k |
| IMMUNOVANT INC IMVT | $6.1m2.22% | Reduced -45.0k |
| INSMED INC INSM | $5.5m1.99% | Added +10.0k |
| EDGEWISE THERAPEUTICS INC EWTX | $5.2m1.89% | New |
| REPLIMUNE GROUP INC REPL | $4.9m1.79% | Unchanged |
| BRIDGEBIO PHARMA INC BBIO | $4.5m1.62% | Added +35.0k |
| TAYSHA GENE THERAPIES INC TSHA | $4.3m1.57% | Added +900.0k |
| RHYTHM PHARMACEUTICALS INC RYTM | $4.1m1.50% | Reduced -38.5k |
| ANNEXON INC ANNX | $3.8m1.40% | Added +340.0k |
| KORRO BIO INC KRRO | $3.7m1.33% | Added +10.0k |
| DYNE THERAPEUTICS INC DYN | $3.6m1.30% | New |
| ARVINAS INC ARVN | $3.6m1.29% | Added +70.0k |
| CORBUS PHARMACEUTICALS HLDGS CRBP | $3.3m1.20% | Reduced -15.0k |
| HELIX ACQUISITION CORP II BBOT | $3.1m1.14% | Unchanged |
| NUVATION BIO INC NUVB | $3.1m1.12% | Added +200.0k |
| SAVARA INC SVRA | $3.1m1.11% | Reduced -325.9k |
| TENAYA THERAPEUTICS INC TNYA | $2.9m1.05% | Added +150.0k |
| REGENXBIO INC RGNX | $2.8m1.01% | Added +95.0k |
| CORVUS PHARMACEUTICALS INC CRVS | $2.6m0.96% | New |
| ABSCI CORPORATION ABSI | $2.1m0.76% | New |
| NEUROGENE INC NGNE | $2.1m0.76% | Reduced -20.0k |
| CAPRICOR THERAPEUTICS INC CAPR | $1.9m0.69% | New |
| APELLIS PHARMACEUTICALS INC APLS | $1.9m0.68% | Reduced -70.0k |
| SUMMIT THERAPEUTICS INC SMMT | $1.9m0.67% | New |
| SPYRE THERAPEUTICS INC SYRE | $1.8m0.64% | Reduced -190.2k |
| VIRIDIAN THERAPEUTICS INC VRDN | $1.7m0.62% | Reduced -512.7k |
| PROQR THRAPEUTICS N V PRQR | $1.6m0.59% | Reduced -12.3k |
| ATYR PHARMA INC ATYR | $1.4m0.51% | Unchanged |
| LARIMAR THERAPEUTICS INC LRMR | $1.3m0.48% | New |
| ENGENE HOLDINGS INC COM | $1.1m0.39% | Reduced -259.4k |
| AMYLYX PHARMACEUTICALS INC AMLX | $1.1m0.38% | New |
Sold out since Q2 2024
| Security | Value then |
|---|---|
| BIOHAVEN LTD BHVN | $17.0m490.0k shares |
| ALNYLAM PHARMACEUTICALS INC ALNY | $5.5m22.5k shares |
| ACADIA PHARMACEUTICALS INC ACAD | $3.7m225.0k shares |
| CABALETTA BIO INC CABA | $2.8m370.9k shares |
| CYTOKINETICS INC CYTK | $1.8m33.2k shares |
| ELEVATION ONCOLOGY INC | $1.6m600.0k shares |
| KRYSTAL BIOTECH INC KRYS | $1.6m8.5k shares |
| WAVE LIFE SCIENCES LTD 96663EUR | $998.0k200.0k shares |
| ARROWHEAD PHARMACEUTICALS IN ARWR | $909.6k35.0k shares |
| SAGIMET BIOSCIENCES INC SGMT | $769.5k225.0k shares |
| INTRA-CELLULAR THERAPIES INC ITCI | $684.9k10.0k shares |
| MACROGENICS INC MGNX | $637.5k150.0k shares |
| PMV PHARMACEUTICALS INC PMVP | $607.5k375.0k shares |
| PTC THERAPEUTICS INC PTCT | $581.0k19.0k shares |
| REVANCE THERAPEUTICS INC RVNC | $578.2k225.0k shares |
| INTELLIA THERAPEUTICS INC NTLA | $559.5k25.0k shares |
| AN2 THERAPEUTICS INC ANTX | $471.6k219.3k shares |
| CYTOMX THERAPEUTICS INC CTMX | $366.0k300.0k shares |
Options (notional value)
| Underlying | Notional | Change |
|---|---|---|
| SPDR SER TR XBI · Put | $29.6m300.0k shares | New |
| BIOHAVEN LTD BHVN · Call | $17.4m348.8k shares | New |
| CORBUS PHARMACEUTICALS HLDGS CRBP · Put | $4.5m220.0k shares | New |
| INSMED INC INSM · Call | $3.6m50.0k shares | Reduced |